Population-Level Testosterone Decline
The Secular Trend, Travison JCEM 2007 and the ~1%/Year Cohort Effect
Evidence grade 3 of 5, Mixed. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- Not an intervention, an epidemiological observation
Reference only. Not medical advice.
What can go wrong
The principal risk is interpretive overreach, converting a public-health observation into individual pathology. Lab assay methods also changed over the period, a measurement caveat sometimes ignored. Lifestyle drivers (obesity, sleep, inactivity) are modifiable and evidence-backed.
This is something to take to a clinician. The Atlas can tell you what is known about population-level testosterone decline in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Multiple cohort studies document a population-level (secular) decline in male testosterone independent of aging. The landmark analysis, Travison et al. (JCEM 2007), using the Massachusetts Male Aging Study, found an age-independent decline of roughly 1% per year per birth cohort, meaning men today have lower testosterone than men of the same age decades ago. The cause is unproven and almost certainly multifactorial: rising obesity, sedentary behavior, sleep loss, chronic stress, dietary shifts, and possible endocrine-disrupting chemicals.
A 30-year-old today has lower testosterone than a 30-year-old in 1980, and we are not sure why.
What people get wrong
Often saidThe testosterone decline proves modern men are being 'feminized' by chemicals
ActuallyWhile endocrine disruptors are a hypothesis, no single cause is proven. Obesity and lifestyle account for a substantial share of the trend, and the 'feminization' framing is a marketing narrative, not an epidemiological finding.
Often saidThis means most men today need TRT
ActuallyA population shift in the mean does not mean individuals are clinically hypogonadal. Most men remain in the normal range; the public-health response points toward weight, sleep, and activity, not mass hormone replacement.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
How we got here
The Travison finding was striking because it could not be explained by the men getting older (age was controlled) or by changes in health status alone, the decline persisted after adjusting for obesity and other factors, pointing to broader generational or environmental influences. European cohorts have reported similar though not identical trends, and some have attributed much of the drop to rising BMI.
The numbers behind the grade
- Cohort decline (MMAS)
- ~1% per year
- Primary suspected drivers
- Obesity, sleep loss, inactivity
- Single proven cause
- None
The people taking it
Documented in US, Danish, and Finnish male cohorts spanning the late 20th to early 21st century; trends are population means and vary by region and methodology.
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Population-Level Testosterone Decline. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
- What people take it for. We have not catalogued the claims made for it.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Travison et al., JCEM, Massachusetts Male Aging Study2007
Total testosterone declined ~1%/year by birth cohort independent of age; a 65-year-old in 2002-04 had lower T than a 65-year-old in 1987-89, beyond what aging or measured health changes explained
Andersson et al. (Danish cohorts)2007
Comparison of Danish birth cohorts suggested a downward shift in serum testosterone across generations
Perheentupa et al. (Finland)2013
Finnish cohorts born later showed lower testosterone than earlier cohorts at matched ages
Lokeshwar et al. (NHANES adolescents/young men)2021
Reported declining testosterone in younger US males, with obesity a major but incomplete explanatory factor